Back

ACAD10 encodes two orphan enzymes in the ether lipid biosynthetic and salvage pathways

Ye, J.; Purlyte, E.; Lopez, V. A.; Kizzar, T.; Tatge, L.; Mill, J.; Baldwin, D.; Rashan, E.; Kim, J.; Pagliarini, D. A.; Tomchick, D. R.; Pawlowski, K.; Douglas, P.; Simcox, J.; Tagliabracci, V. S.

2025-09-13 biochemistry
10.1101/2025.09.10.675409 bioRxiv
Show abstract

Ether lipids play critical roles in membrane dynamics, antioxidant defense, and signaling. They comprise [~]20% of mammalian phospholipids, and disruptions in their metabolism cause severe genetic disorders and are associated with neurodegenerative and metabolic diseases. Ether lipids are synthesized de novo from glycolytic intermediates or salvaged from the diet. While the products of these pathways are known, several key enzymes remain unidentified, including the 1-O-alkylglycerol kinase and the 1-O-alkyl-2-acetyl-sn-glycero-3-phosphate phosphatase. Here, we show that acyl-CoA dehydrogenase member 10 (ACAD10) catalyzes the phosphorylation of 1-O-alkylglycerols and the dephosphorylation of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphate. Worms and mice lacking ACAD10 have reduced ether lipid levels and cannot salvage dietary alkylglycerols. Furthermore, individuals from the Akimel Oodham (Pima) tribe carrying ACAD10 polymorphisms also show decreased plasma ether lipid levels. Collectively, our findings resolve two long-standing gaps in ether lipid biochemistry and reveal a mechanistic link between ether lipid metabolism and a population-associated risk factor for type 2 diabetes.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.